XML 17 R6.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid in Capital
Accumulated deficit
Accumulated Other Comprehensive Loss
Treasury Stock
Balance (in shares) at Dec. 31, 2018   17,878,000       1,708,000
Balance at Dec. 31, 2018 $ 45,946 $ 357 $ 50,251 $ 5,427 $ (4,253) $ (5,836)
Net loss (2,729)     (2,729)    
Issuance of common stock upon the exercise of stock options (in shares)   78,000        
Issuance of common stock upon the exercise of stock options 30   30      
Stock-based compensation 248   248      
Foreign currency translation adjustments (10)       (10)  
Balance (in shares) at Mar. 31, 2019   17,956,000       1,708,000
Balance at Mar. 31, 2019 43,485 $ 357 50,529 2,698 (4,263) $ (5,836)
Balance (in shares) at Dec. 31, 2018   17,878,000       1,708,000
Balance at Dec. 31, 2018 45,946 $ 357 50,251 5,427 (4,253) $ (5,836)
Net loss (9,740)          
Foreign currency translation adjustments (236)          
Balance (in shares) at Sep. 30, 2019   18,053,000       1,708,000
Balance at Sep. 30, 2019 50,556 $ 362 64,832 (4,313) (4,489) $ (5,836)
Balance (in shares) at Mar. 31, 2019   17,956,000       1,708,000
Balance at Mar. 31, 2019 43,485 $ 357 50,529 2,698 (4,263) $ (5,836)
Net loss (1,109)     (1,109)    
Issuance of common stock upon the exercise of stock options (in shares)   79,000        
Issuance of common stock upon the exercise of stock options 213 $ 3 210      
Stock-based compensation 602   602      
Foreign currency translation adjustments 131       131  
Convertible notes conversion discount 12,465   12,465      
Balance (in shares) at Jun. 30, 2019   18,035,000       1,708,000
Balance at Jun. 30, 2019 55,787 $ 360 63,806 1,589 (4,132) $ (5,836)
Convertible notes conversion discount, taxes 4,100          
Issuance cost, equity component 1,100          
Net loss (5,902)     (5,902)    
Issuance of common stock upon the exercise of stock options (in shares)   18,000        
Issuance of common stock upon the exercise of stock options 40 $ 2 38      
Stock-based compensation 988   988      
Foreign currency translation adjustments (357)       (357)  
Balance (in shares) at Sep. 30, 2019   18,053,000       1,708,000
Balance at Sep. 30, 2019 $ 50,556 $ 362 64,832 (4,313) (4,489) $ (5,836)
Balance (in shares) at Dec. 31, 2019 16,629,177 18,360,000       1,731,000
Balance at Dec. 31, 2019 $ 72,847 $ 367 94,372 (10,144) (5,368) $ (6,380)
Net loss (10,910)     (10,910)    
Issuance of common stock upon the exercise of stock options (in shares)   2,000        
Issuance of common stock upon the exercise of stock options 30   30      
Net issuance of restricted stock awards (in shares)   21,000        
Net issuance of restricted stock awards 0          
Treasury stock acquired from employees upon vesting or forfeiture of restricted stock (in shares)           38,000
Treasury stock acquired from employees upon vesting or forfeiture of restricted stock (524)         $ (524)
Issuance of restricted stock for acquisition (in shares)   908,000        
Issuance of restricted stock for acquisition 19 $ 19        
Equity component of redeemed 2024 convertible notes (in shares)           (722,000)
Equity component of redeemed 2024 convertible notes (5,553)   (7,988)     $ 2,435
Equity component of issued 2026 convertible notes 19,097   19,097      
Stock-based compensation 1,089   1,089      
Foreign currency translation adjustments 201       201  
Balance (in shares) at Mar. 31, 2020   19,291,000       1,047,000
Balance at Mar. 31, 2020 $ 76,296 $ 386 106,600 (21,054) (5,167) $ (4,469)
Balance (in shares) at Dec. 31, 2019 16,629,177 18,360,000       1,731,000
Balance at Dec. 31, 2019 $ 72,847 $ 367 94,372 (10,144) (5,368) $ (6,380)
Net loss $ (23,597)          
Issuance of common stock upon the exercise of stock options (in shares) 25,000          
Foreign currency translation adjustments $ 309          
Balance (in shares) at Sep. 30, 2020 18,263,416 19,315,000       1,052,000
Balance at Sep. 30, 2020 $ 66,775 $ 386 109,772 (33,741) (5,059) $ (4,583)
Balance (in shares) at Mar. 31, 2020   19,291,000       1,047,000
Balance at Mar. 31, 2020 76,296 $ 386 106,600 (21,054) (5,167) $ (4,469)
Net loss (8,976)     (8,976)    
Issuance of common stock upon the exercise of stock options (in shares)   4,000        
Issuance of common stock upon the exercise of stock options 12   12      
Treasury stock acquired from employees upon vesting or forfeiture of restricted stock (in shares)           3,000
Treasury stock acquired from employees upon vesting or forfeiture of restricted stock (3)   (195)     $ 192
Stock-based compensation 1,123   1,123      
Foreign currency translation adjustments 158       158  
Balance (in shares) at Jun. 30, 2020   19,295,000       1,050,000
Balance at Jun. 30, 2020 68,610 $ 386 107,540 (30,030) (5,009) $ (4,277)
Net loss (3,711)     (3,711)    
Issuance of common stock upon the exercise of stock options (in shares)   20,000        
Issuance of common stock upon the exercise of stock options 394   394      
Net issuance of restricted stock awards 833   833      
Treasury stock acquired from employees upon vesting or forfeiture of restricted stock (in shares)           2,000
Treasury stock acquired from employees upon vesting or forfeiture of restricted stock (306)         $ (306)
Stock-based compensation 1,005   1,005      
Foreign currency translation adjustments $ (50)       (50)  
Balance (in shares) at Sep. 30, 2020 18,263,416 19,315,000       1,052,000
Balance at Sep. 30, 2020 $ 66,775 $ 386 $ 109,772 $ (33,741) $ (5,059) $ (4,583)